318 related articles for article (PubMed ID: 22122637)
21. The cancer stem-cell signaling network and resistance to therapy.
Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
[TBL] [Abstract][Full Text] [Related]
22. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
23. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
24. Twist1 and Snail link Hedgehog signaling to tumor-initiating cell-like properties and acquired chemoresistance independently of ABC transporters.
Kong Y; Peng Y; Liu Y; Xin H; Zhan X; Tan W
Stem Cells; 2015 Apr; 33(4):1063-74. PubMed ID: 25588661
[TBL] [Abstract][Full Text] [Related]
25. Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance.
Vitale D; Kumar Katakam S; Greve B; Jang B; Oh ES; Alaniz L; Götte M
FEBS J; 2019 Aug; 286(15):2870-2882. PubMed ID: 31230410
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer chemoresistance: emerging importance of cancer stem cells.
Chuthapisith S; Eremin J; El-Sheemey M; Eremin O
Surg Oncol; 2010 Mar; 19(1):27-32. PubMed ID: 19251410
[TBL] [Abstract][Full Text] [Related]
27. The role of CD44 in cancer chemoresistance: A concise review.
Yaghobi Z; Movassaghpour A; Talebi M; Abdoli Shadbad M; Hajiasgharzadeh K; Pourvahdani S; Baradaran B
Eur J Pharmacol; 2021 Jul; 903():174147. PubMed ID: 33961871
[TBL] [Abstract][Full Text] [Related]
28. Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.
Jung Y; Park H; Zhao HY; Jeon R; Ryu JH; Kim WY
Mol Cells; 2014 Jul; 37(7):547-53. PubMed ID: 25078449
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
[TBL] [Abstract][Full Text] [Related]
30. Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics.
Tandon I; Waghmode A; Sharma NK
Curr Cancer Drug Targets; 2019; 19(11):877-884. PubMed ID: 31393247
[TBL] [Abstract][Full Text] [Related]
31. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
[TBL] [Abstract][Full Text] [Related]
32. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
Cojoc M; Mäbert K; Muders MH; Dubrovska A
Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
Zardawi SJ; O'Toole SA; Sutherland RL; Musgrove EA
Histol Histopathol; 2009 Mar; 24(3):385-98. PubMed ID: 19130408
[TBL] [Abstract][Full Text] [Related]
34. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
[TBL] [Abstract][Full Text] [Related]
36. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
Shimizu T; Nakagawa K
Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
[TBL] [Abstract][Full Text] [Related]
37. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
[TBL] [Abstract][Full Text] [Related]
38. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.
McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM
Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668
[TBL] [Abstract][Full Text] [Related]
39. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.
Capodanno Y; Buishand FO; Pang LY; Kirpensteijn J; Mol JA; Argyle DJ
Endocr Relat Cancer; 2018 Feb; 25(2):131-144. PubMed ID: 29175872
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
Alonso S; Jones RJ; Ghiaur G
Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
